Wall Street Zen has upgraded Pool (NASDAQ:POOL) from "sell" to "hold" after the company missed quarterly earnings and revenue estimates and set a lower-than-consensus FY2026 guidance. Despite analysts trimming price targets, the stock maintains a "Hold" consensus rating with an average target price significantly above its current trading price. Insider transactions show both a CFO sale and a Director purchase, while institutional investors have slightly adjusted their positions in the company.

Wall Street Zen has downgraded Regeneron Pharmaceuticals (NASDAQ:REGN) from a "Buy" to a "Hold" rating. Despite this downgrade, other analysts collectively rate REGN a "Moderate Buy" with a consensus target price of $811.96. The company recently exceeded quarterly earnings and revenue estimates, though insiders sold a significant number of shares recently.

Wall Street Zen has upgraded Priority Technology (NASDAQ:PRTH) from a "hold" to a "buy" rating, though overall analyst consensus remains "Hold" with a target price of $8.75. The company recently missed earnings estimates, reporting $0.27 EPS against $0.29 expected, and has a negative return on equity of 66.5%. Institutional investors have increased their holdings, with several large firms purchasing new stakes in the third quarter.

The article reports that State Street stock has surged by 14% and is currently experiencing a nine-day winning streak. The content provided is minimal, primarily serving as boilerplate text for the Trefis platform.

Wall Street Zen has upgraded CF Industries (NYSE:CF) from a "hold" to a "buy" rating, contributing to a stock price increase. The company recently exceeded earnings estimates with EPS of $2.59 and saw a 22.8% year-over-year revenue increase. However, the MarketBeat consensus remains a "Hold" with a target of $112.27, and the stock faces risks from geopolitical developments in the Persian Gulf and recent insider selling.

Wall Street Zen has downgraded Bristol Myers Squibb (NYSE:BMY) from a "strong-buy" to a "buy" rating. This adjustment comes amidst a mixed analyst outlook, with the company missing quarterly EPS estimates despite revenue beats, and facing near-term earnings risks due to generic erosion and analyst caution. The article also highlights recent insider trading activity and institutional investor movements, alongside key news stories impacting the company.

Wall Street Zen has upgraded Dollar Tree (NASDAQ:DLTR) from a "hold" to a "buy" rating, though overall analyst consensus remains "Hold" with a $123.24 price target. The company recently exceeded EPS expectations but slightly missed revenue estimates, reporting quarterly EPS of $2.56 against predictions of $2.53, with revenue reaching $5.45 billion. Dollar Tree's shares opened at $99.55, reflecting a market capitalization of $19.64 billion and strong institutional ownership.

Wall Street Zen has upgraded Pangaea Logistics Solutions (NASDAQ:PANL) from a "buy" to a "strong-buy" rating, despite a consensus "Hold" rating among analysts with an average price target of $9.00. The company recently reported quarterly EPS of $0.16, missing estimates, but revenue slightly beat expectations at $183.88 million. PANL shares opened at $7.29, with a market cap of approximately $476 million and institutional ownership around 60%.

Wall Street Zen has upgraded NetApp (NASDAQ:NTAP) from a "hold" to a "buy" rating, indicating a bullish outlook for the data storage provider. Despite a mixed analyst consensus, with an average "Hold" rating and a price target of $122.42, NetApp recently surpassed earnings and revenue expectations. The company also provided optimistic guidance for Q4 2026 and the full fiscal year 2026.

Wall Street Zen has upgraded Essex Property Trust (NYSE:ESS) from a "strong sell" to a "sell" rating, though the general analyst consensus remains a "Hold" with a target price of $282. The real estate investment trust recently reported its Q4 earnings, missing EPS estimates slightly but exceeding revenue expectations, and provided its FY2026 and Q1 2026 EPS guidance. Various other analysts have adjusted their price targets, with some trimming their outlook despite the slight upgrade in rating from Wall Street Zen.